Online Event

International conference on

Respiratory Diseases and Pulmonology

Theme: The Global Impact of Respiratory Diseases and latest Pulmonology Medicine

Event Date & Time

Event Location

Online Event

Program Abstract Registration Awards 2020

18 years of lifescience communication


Performers / Professionals From Around The Globe

Tracks & Key Topics

Pulmonology 2020



International COPD 2019 cordially invites participants from all over the world to attend “International conference on Respiratory Diseases and Pulmonology”.  International COPD 2019 is a two day conference scheduled during September 28-29, 2020 at Berlin, Germany on the theme “The Global Impact of Respiratory Diseases and latest Pulmonology Medicine” which include prompt Keynote presentations, Oral Presentations, Poster presentations, Young Research Forum, Workshops and Exhibitions.

Who should attend?
  • Pulmonologist
  • Medical Colleges
  • Pulmonology Associations and Societies
  • Research Labs
  • Manufacturing Medical Devices Companies
  • Doctors and Surgeons in COPD and Lung disorder
  • Academic professionals
  • Research Scientists and their members
  • Business Entrepreneur
  • Medical equipment manufacturers
  • University and training institutions
Why to attend?
International COPD 2019 provides a golden opportunity to meet with the leading national and international speakers who will discuss the latest advancements in COPD congress and to the related diseases worldwide. Conference unites individuals or eminent personalities from all over the world, who share a common discipline or field. This conference is a collaborative event for the researchers from both business and academic background and offers current and recent information on the management of Asthma, lung cancer, as well as the possible therapies and strategies to shape the future of lung and COPD research. We encourage physicians, nurses, researchers and scientists as well as patients and advocates in the pulmonology field and those interested in attending this 2-days Conference.
Top Associations and Societies of COPD:
  • American Academy of Allergy
  • American Association for Respiratory Care
  • American Lung Association
  • American Thoracic Society
  • Australian Lung Foundation
  • Asthma Society of Canada
  • Asthmaand Allergy Foundation of America
  • Asthma and Respiratory Foundation NZ
  • Breathe the Lung Association
  • British Lung Foundation
  • British Thoracic Society
  • Canadian Thoracic Society
  • COPD Patient Organization of Vietnam
  • Global Initiative for Chronic Obstructive Lung Disease
  • Infectious Diseases Society of America
  • Lung Foundation Australia
  • National Lung Health Education Program
  • National Heart
  • Lung and Blood Institute
  • National Institutes of Health


Asthma and COPD

Asthma is a typical fiery infection in aviation routes of the lungs. Asthma influences within dividers of aviation routes are swollen or flared and cause unfavourably susceptible asthma. Swelling makes the aviation routes significantly smaller. Cells in the aviation routes will in general reason more bodily fluid generation. Discharge is a thick, sticky fluid that can facilitate slim aviation routes. This chain response can result in respiratory infection side effects and may cause unfavourably susceptible maladies. It is mostly described by reversible wind stream obstacle and bronchospasm. Asthma is characterized by the recurrence of side effects, constrained expiratory volume in one moment, and pinnacle expiratory stream rate. These measures may happen a couple of times each day or a couple of times each week. Contingent upon the individual, they may turn out to be more awful around evening time or with exercise. Asthma can't be restored however with better treatment, individuals can control and dynamic their lives.

Epidemiology Of COPD

Chronic obstructive pulmonary disease (COPD) is accountable for early impermanence, high death rates and significant rate to health systems. Active smoking remains the main risk factor, but other issues are becoming better known, such as occupational factors, infections and the role of air pollution. The occurrence of COPDdiffers according to country, age, and sex. This disease is also associated with significant comorbidities. COPD is a complaint that contains various phenotypes, the continuum of which remains under debate. The major challenge in the coming years will be to prevent the onset of smoking along with early recognition of the disease in the general population. This may represent weakening in the patient's premorbid condition such that hypoxemia worsens, and hypercapniaprogresses during a comparatively inconsequential respiratory tract infection, which may be viral or bacterial. 

  •  Air Pollution
  • Occupational Factors
  • Short of Breath 

 Idiopathic pulmonary fibrosis:

Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that consequences in scarring (fibrosis) of the lungs for an unidentified reason. Over time, the scarring gets worse and it becomes hard to take in an unfathomable breath and the lungs cannot take in enough oxygen. IPF is a form of interstitial lung disease, primarily relating the interstitial (the tissue and space around the air sacs of the lungs), and not right affecting the airways or blood vessels. There are many other types of interstitial lung disease that can also reason inflammation and/or fibrosis, and these are treated inversely.

Immune Responses in COPD:

In chronic pulmonary disease immune dysfunction happens. Chronic irritationcontributes to lung damage, involves of innate and adaptive immune responses. wide-ranging immune dysfunction due to the occurrence and functional action of T regulatory cells, CD4+ exhausted effector T cells and myeloid-derived suppressor cells. Manipulation of these immunosuppressive systems in COPDcould deliver a rational strategy to restore functional immune responses, decrease exacerbations, and progress lung function. It facilitates the occurrences of respiratory tract infections additional proceeds to the pathological appearances of the disease. Inflammation is conveyed by the initiation of defective immune responses that support to worsening the inflammatory lung and disease brutality. Advanced approaches to adaptive immune responses could be beneficial in avoiding the adverse consequences of most of the inflammatory responses in the lungs.

Advanced Respiratory Disease Treatment

Currently, patients with Respiratory diseasesuse numerous devices, which help the subtraction of mucus from the Airways and the development of pulmonary function. Monotonous respiratory organ accomplishes, and metabolism muscle testing is recommended in youngsters with Neuromuscular Disease, however, these trials are maintained non-invasive voluntary manoeuvres, like the measuring of respiratory organ volumes and supreme static pressures, which young youngsters might not forever be able to achieve. Fundamentally, before the treatment Observation metabolism muscles in youngsters with NMD might advance understanding of the explanation of NMD and therefore the analysis of sickness severity. Now devices seem to increase patients' compliance with regular treatment, because they present many assistances, as an independent application, full control of therapy and easy use.

  • Lung Transplantation in Cystic Fibrosis
  • Positive Airway Pressure Therapy
  • Physiotherapy
  • Physical Examination

Lung Carcinoma

Lung cancer is the foremost reason of cancer-related death worldwide. About 85% of cases are correlated to cigarette smoke and is a malignant tumor characterized by uncontrolled cell growth in tissues of lungs and infrequently to other parts of the body. The cases are frequently caused by a combination of genetic factors and exposure to radon gas, second-hand smoke, asbestos or other forms of air pollution. Lung cancer may be perceived on computed tomography and chest radiographs. Lung cancers are of two types, they cultivate and spread differently are small cell lung cancer and non-small cell lung cancers. The lungs are giant, the tumor grows in them for a continued time before they are found. Small-cell lung cancer signifies about 15 to 20 %of lung cancers whereas Non-Small cell lung cancer represents about 80%. More than two-thirds of non-smokers having lung cancer are women, and maximum of them possess adenocarcinoma. The universal diagnosis of lung cancer is poor because doctors tend not to find the disease until it is at a progressive phase. The persistence rate in five years is around 54% for early phase lung cancer that is restricted to the lungs, but only around 4% in advanced, inoperable lung cancer.


Radiation therapy

Pulmonary lobectomy


Chronic respiratory infections

Pediatric Pulmonology

Chronic pulmonary disorder is a chief risk issue of children’s death. The sequence of studies on pediatric pulmonary disorderspecifies overlapping age clusters from birth to late middle age that early life event which includes prenatal influences on lung growthand agendas the child at increased risk for future COPD. Several signs are phlegm production, chronic cough, frequent lung infections, and trouble doing daily activities because of breathlessness. Pediatric pulmonology is based on diagnosis, treatment, and accomplish children from birth to 21 years old with breathing and lung diseases. The COPD disorders in infants comparable pneumonia, asthma, tuberculosis, complicated chest infections are cured pediatric pulmonologists.

  • Dysplasia
  • Interstitial lung disease
  • Cystic fibrosis
  • Recurrent aspiration

Pathophysiology of COPD

Fundamentally, the pathophysiology of COPDis quickly unveiling. There will be some physiological modification which ultimately impacts the quality of life and survival in the natural progress of COPD when the pathological significances of the COPDinflammation induce a sequence of physiological changes. Fibrotic remodeling of the airways results in fixed airway narrowing initiating increased airway resistance which does not completely revert even with bronchodilators. Emphysema also decreases lung elastic recoil pressure which leads to a reduced driving pressure for expiratory flow through narrowed and poorly supported airways in which airflow resistance is significantly increased.

Antitrypsin Deficiency

Bronchial Hyperreactivity


Pulmonary Hypertension

Pulmonary hypertension is a kind of high blood pressure that disturbs the arteries in the lungs and the right side of the heart. These are the serious environments that become progressively worse and are occasionally fatal. These fluctuations can reason the walls of the arteries to become thick and stiff, and extra tissue may form. The blood vessels can also become inflamed and tight. The symptoms are categorized by chest pain, swelling in ankles, legs.  Although some arrangements of pulmonary hypertension aren't curable, treatment can help lessen symptoms and improve the superiority of life. Moreover, pregnancy may have thoughtful threats for women with pulmonary hypertension, so be sure to discuss birth control decisions with the physician.

Gene mutation

Congenital heart disease



Liver disease

Respiratory diseases

Respiratory diseases are the common and important reason of illness and death around worldwide. In the UK, approximately 1 in 7 individuals are affected by some category of chronic lung disease. People with respiratory disease have trouble respiration from a limitation in processing air out of lungs which further can cause emphysema and chronic bronchitis. The tissues and organs that make exchange of gas probable in higher organisms, and includes conditions of trachea, bronchi, upper respiratory tract, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing occurs in case of uncontrolled situations. They are characterized by a high inflammatory cell recruitment or destructive cycle of infection. Some of the most common are asthma, chronic obstructive pulmonary disease, pulmonary effusion. As CRDs are not remediable; however, various forms of treatment that help dilate major air passages and improve shortness of breath can support control symptoms and increase the quality of life for people with the diseases.

Acute respiratory distress syndrome

Respiratory failure

Hypersensitivity pneumonitis

Pulmonary fibrosis

Upper Respiratory tract infections

COPD and Cardiovascular Diseases

Chronic obstructive pulmonary disease is associated with an increased chance of cardiovascular disease, for instance, heart failure or a heart attack. The lungs and the heart work stably together to supply the oxygen; oxygen in the air comes into the lungs is moved into the circulation system, which the heart by then impulses out to rest of the body. Though, diseases in both the heart and the lungs regularly go together. If any person has COPD at that point, there is a higher risk of having cardiovascular diseases. Comorbiditiesand chronic obstructive pulmonary disease (COPD) are universal, with cardiovascular disease being the most notable and significant. COPD Conferences will focus on the scope of COPD associated with cardiovascular diseases.

Depression and anxiety in COPD

Depression and anxiety in COPD are characteristics in patients who are suffering for chronic obstructive pulmonary disease (COPD), assessments of their pervasiveness differ significantly. This probably reflects the diversity of scales and techniques used to measure such symptoms. Patients with COPD with three or more comorbidities more likely to be often hospitalized and may die prematurely compared with COPD patients without comorbidities. An elevated experience of dyspnoea is a probable contributing segment to nervousness. Feelings of depression may be precipitated by the loss and grief related to the incapability of COPD. Smoking has related to nicotine addiction, and the variables that subsidize to smoking may also influence to anxiety and depressive disorders. The cause of depression and anxiety manifestations are multifactorial and include behavioural, social and biological factors. COPD Conferencescovers a way towards a break-through in pulmonology exploration field.

Self-Management and Prevention of COPD

Self-Management and Prevention of COPDinterventions assist patients who are suffering for chronic obstructive pulmonary disease (COPD) acquire and practice the skills they need to carry out disease medical regimens, guide changes in health behavior and offer passionate help to empower patients to control their ailment. Patients who are suffering from spirometry and symptoms and airflow obstruction should be checked frequently to guide modification of treatmentand to differentiate complications early. All the Pulmonology Conferences will be attentive around the self-management support programmes should be combined between healthcare professionals and patients, to permit them to protect abilities to recognize and achieve with their medications and exacerbations of COPD, embrace healthier behaviors and deal with the social-emotional significances of the disease.


Drug Discovery of COPD


COPD is one of the most communal diseasesin the world, and there is a global increase in occurrence, but there are no drugs available at present that halt the unremitting progression of this disease. However, a better understanding of the cellular and molecular mechanisms that are involved in the underlying inflammatory and destructive processes has revealed several new goals for which drugs are now in development, and the prospects for finding new treatments are good. Generally, Lung Conferences will focus on the different techniques used in pulmonology.

Genetic risk factor of COPD

Even if an individual has never smoked or been defenseless to pollutants for an extended period, they can still progress COPD. Alpha-1 Antitrypsin Deficiency (AATD) is the most frequently known hereditary hazard factor of COPD in emphysema. Alpha-1 Antitrypsinrelated COPD is caused by the inherent deficiency of the Alpha-1 in the circulatory system. Without the Alpha-1 Antitrypsin protein, white platelets in blood start to harm the lungs and lung deterioration occurs. The World Health Organization and the American Thoracic Society proposes that every individual resolute to have COPD be tested for Alpha-1. All the Pulmonology Conferences also discusses different categories of genes which may be a cause of pulmonary diseases.

COPD Complications:

Individuals with COPD can be at risk for grave complications that can put their security in risk, as well as be fatal. Acute COPD Exacerbations are represented by an unanticipated addition of manifestations. Cough and sputum production increases generally. At the point when respiratory failurearises in a patient who gradually, there is a moderate decrease in lung capacity and rising levels of carbon dioxide in the blood. The growing carbon dioxide has a sedative effecton the patient, who gradually loses consciousness and quite relaxing. Different complications of COPD incorporate pneumonia, polycythemia, and pneumothorax, etc. Pneumonia instigated by the bacterial disease can prompt respiratory failure in these patients. Streptococcus pneumoniae is the most outstanding reason behind bacterial pneumonia in patients with COPD. Pneumothorax happens when a hole develops in the lung, empowering air to escape into the space between the lung and the chest wall and collapsing the lung. Polycythaemia in COPD is the body's endeavor to adjust to decreased amount of blood oxygen by expanding the generation of oxygen-passing on red blood cells. While this might be useful temporarily, overproduction eventually clogs small blood vessels. Lung Conferences expresses various developing treatments for COPD.

Pulmonary Rehabilitation

All-inclusive pulmonary rehabilitation is an imperious part of the clinical supervision of people with chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation is a program of progressive exercise and education supervised by a physiotherapist for individuals with COPD. In the study of pulmonary rehabilitation, you will also learn about the breathing techniques, medications, proper nutrition for COPD patients, relaxation, oxygen, travel, how to do ordinary undertakings with less shortness of breath. Lung Conferences provides a global forum for discussion about the innovation of pulmonology research.

Tuberculosis and COPD

Tuberculosis and Chronic Obstructive Pulmonary Disease convey about a significant concern in terms of morbidity and mortality all-over the world. This spotlight on various portions of tuberculosis as far as the association with COPD such as in the advancement of chronic airflow obstruction as an outcome of active tuberculosis and assessing the key protagonist of cigarette smoking in the pathogenesis of both conditions. Patients determined to have tuberculosis may regularly have extensive co-morbidity such as COPD and the impact of an underlying diagnosis of COPD on results in tuberculosis is also reviewed. COPD Conferences explores all the new ideas and techniques of pulmonary therapy.

Airway obstruction

Genetic Vulnerability

Common Risk factors

Pneumonia and COPD

People who are suffering from COPD will probably create pneumonia. Pneumonia is particularly unsafe for individuals with COPD by causing an increased risk of respiratory failure. This is the fact at which your body is either not getting enough oxygen or isn't effectively expelling carbon dioxide. Pneumonia and COPD can result in serious complications. Long term and even permanent damage can occur. Early treatment can help decrease these risks. The inflammation from pneumonia can constrain your airflow, which can further damage your lungs. This can progress into acute respiratory failure, which can be fatal. COPD Conferences enlighten the recent advances in COPD and pulmonology research.



Surgical Interventions and Therapies in COPD

The conditions of the obstructive pulmonary disease can be prevented by decreasing contact with risk factors. It comprises decreasing rates of smoking and improving indoor and outdoor air quality. Irrespective of frequent medical treatments, surgery may be measured for the symptomatic patient with medically-optimized, end-stage COPD. Effective management of COPD is constructed on the ability to slow disease progression, prevent infection, and treat reversible symptoms. Several agents are available for the management of reversible bronchospasm associated with COPD. People having advanced chronic pulmonary conditions undergo several treatments like bronchoscopy. The goal of surgical interventions and therapy of chronic lung disease is to prolong life by preventing secondary complications, to relieve dyspnea, and to enhance the quality of life by improving functional status.

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!